| 中文名 | (8a,9R)-辛可宁-9-醇单[[(S)-[(1R)-2-甲基-1-(1-氧代丙氧基)丙氧基](4-苯基丁基)氧膦基]乙酸]盐 |
|---|---|
| 英文名 | (8a,9R)-Cinchonan-9-ol mono[[(S)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetate] |
| 中文别名 | 辛可宁-9-醇[[(S)-[(1R)-2-甲基-1-(1-氧代丙氧基)丙氧基](4-苯基丁基)氧膦乙酸酯 |
| 英文别名 |
Cinchonan-9-ol Mono[[(S)-[(1R)-2-Methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetate]
[R-(R*S*)][[2-Methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl]acetic acid (-)-cinchonidine (1:1) salt Fosinopril Intermediate 1 [(2-Methyl-1-Propionylpropoxy)(4-Phenylbutyl)Phosphinoyl]Acetic Acid-Cinchonidine (R)-Quinolin-4-yl((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)Methanol 2-(((R)-2-Methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetic acid(1:1) |
| 分子式 | C38H51N2O7P |
|---|---|
| 分子量 | 678.79500 |
| 精确质量 | 678.34300 |
| PSA | 136.07000 |
| LogP | 7.42640 |
| 危害码 (欧洲) | Xi |
|---|---|
| 风险声明 (欧洲) | R41 |
| 安全声明 (欧洲) | 24-26-37/39-61 |